Elicio Therapeutics Stock Forecast

Sell candidate since Jun 15, 2026 Gain 0.74%

The Elicio Therapeutics, Inc. stock price fell by -0.725% on the last day (Tuesday, 23rd Jun 2026) from $4.14 to $4.11. During the last trading day the stock fluctuated 10.83% from a day low at $3.97 to a day high of $4.40. The price has been going up and down for this period, and there has been a -69.67% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -2 million shares and in total, 2 million shares were bought and sold for approximately $6.38 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.62 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -13.02% during the next 3 months and, with a 90% probability hold a price between $2.28 and $12.52 at the end of this 3-month period.

ELTX Signals & Forecast

There are few to no technical positive signals at the moment. The Elicio Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $5.50 and $10.17. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, June 17, 2026, and so far it has fallen -12.74%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Elicio Therapeutics, Inc. stock

Elicio Therapeutics, Inc. finds support from accumulated volume at $4.08 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.430 between high and low, or 10.83%. For the last week, the stock has had daily average volatility of 48.03%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ELTX) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Elicio Therapeutics, Inc. to open at $4.16, and during the day (based on 14 day Average True Range), to move between $3.22 and $5.00, which gives a possible trading interval of +/-$1.77 (+/-54.99%) up or down from last closing price. If Elicio Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 54.99% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $4.14 (0.73%) than the support at $4.08 (0.73%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Elicio Therapeutics, Inc. stock A Buy?

Elicio Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -6.156 Strong Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $4.16 ( 1.22%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk